More on Mast Therapeutics Q2 results

Mast Therapeutics (MSTX) Q2 results: Revenues: $0; Net Loss: ($7.2M) (-44.7%); Loss Per Share: ($0.06) (+33.3%); Quick Assets: $46.4M (+4.5%).

No financial guidance given.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs